Abstract
In a three-phase study that began in 1969, prazosin was shown to be especially suitable for use in treatment of hypertensive patients with gout, renal disease, or borderline diabetes, owing to the sparing of organ systems often harmed by other antihypertensive drugs.
MeSH terms
-
Adult
-
Aged
-
Antihypertensive Agents / adverse effects
-
Antihypertensive Agents / therapeutic use*
-
Clinical Trials as Topic
-
Drug Therapy, Combination
-
Female
-
Humans
-
Hypertension / complications
-
Hypertension / drug therapy*
-
Hypertension / physiopathology
-
Hypertension, Renal / drug therapy
-
Male
-
Middle Aged
-
Piperazines / adverse effects
-
Piperazines / therapeutic use
-
Polythiazide / therapeutic use
-
Quinazolines / adverse effects
-
Quinazolines / therapeutic use*
-
Reserpine / therapeutic use
-
Time Factors
Substances
-
Antihypertensive Agents
-
Piperazines
-
Quinazolines
-
Polythiazide
-
Reserpine